Interestingly, these resident progenitor cells have been demonstrated to differentiate into a variety of cell types, including those of the vascular lineage, in response to specific culture conditions in vitro. 13 Although seminal studies implicate the © 2013 American Heart Association, Inc. Objective-This study was designed to carry out the characterization of stem cells within the adventitia and to elucidate their functional role in the pathogenesis of vein graft atherosclerosis. Approach and Results-A mouse vein graft model was used to investigate the functional role of adventitial stem/progenitor cells on atherosclerosis. The adventitia of vein grafts underwent significant remodeling during early stages of vessel grafting and displayed markedly heterogeneous cell compositions. Immunofluorescence staining indicated a significant number of stem cell antigen-1-positive cells that were closely located to vasa vasorum. In vitro clonogenic assays demonstrated 1% to 11% of growing rates from adventitial cell cultures, most of which could be differentiated into smooth muscle cells (SMCs). These stem cell antigen-1-positive cells also displayed a potential to differentiate into adipogenic, osteogenic, or chondrogenic lineages in vitro. In light of the proatherogenic roles of SMCs in atherosclerosis, we focused on the functional roles of progenitor-SMC differentiation, in which we subsequently demonstrated that it was driven by direct interaction of the integrin/collagen IV axis. The ex vivo bioreactor system revealed the migratory capacity of stem cell antigen-1-positive progenitor cells into the vessel wall in response to stromal cell-derived factor-1. Stem cell antigen-1-positive cells that were applied to the outer layer of vein grafts showed enhanced atherosclerosis in apolipoprotein E-deficient mice, which contributed to ≈30% of neointimal SMCs. Conclusions-We demonstrate that during pathological conditions in vein grafting, the adventitia harbors stem/ progenitor cells that can actively participate in the pathogenesis of vascular disease via differentiation into SMCs.
A utologous vein grafts remain the only surgical alternative for many types of vascular reconstruction, but the patency rate is still limited because of neointima formation and atherosclerosis within the grafted vessels. 1 Neointimal hyperplasia in vein grafts seems to facilitate the acceleration of subsequent vein graft atherosclerosis, 2 but the mechanisms of neointimal formation in vein grafts remain unclear. We demonstrated that the earliest cellular event in mouse vein grafts is cell death, either via apoptosis or necrosis, 3 followed by inflammation and cell proliferation within the grafts. 4 Nevertheless, the hallmark of vein graft pathology includes marked alterations in the adventitial layer of the vessel wall, as indicated by increased cell infiltration and hyperplasia. 5 Indeed, cell densities and neovascularization were found to be significantly increased in the adventitia of vein grafts 2 weeks after surgery. 5 Although it is known that adventitia plays a part in the neointimal formation after vessel injury, 6 the functional roles of defined cell populations within the specialized compartment in the pathogenesis of vein graft atherosclerosis remain clarified. The adventitia is composed of a vast network of connective tissue and cell populations that include collagen fibers, vasa vasorum, nerve endings, a few quiescent resident inflammatory cells, fibroblasts, and other cells. 7 The complex network of cellular and molecular players that serve as building blocks within the vascular adventitia is required to act as a biological processing center for the retrieval, integration, storage, and release of key regulators for functional maintenance of the vessel wall. [8] [9] [10] [11] More recently, accumulating evidence implicated the presence of stem/progenitor cells within the adventitia of the vessels. [12] [13] [14] importance of adventitial stem/progenitor cells during physiological conditions, 13 the functional roles of adventitial stem/ progenitor cells in pathological conditions as seen in vein grafts are not known, especially in their potential contribution toward atherosclerosis and neointimal hyperplasia. Furthermore, previous work has mostly focused on the putative roles of cellular players that were derived from either the intima or media. In the present study, we hypothesize that stem/progenitor cells in the adventitia of vein grafts can participate in neointimal formation. Thus, we first aimed to investigate the phenotypic and functional characterization of the adventitial-derived stem/progenitor cells from vein grafts. Subsequently, we dissected the mechanisms that mediate their contribution toward the pathogenesis of vein graft atherosclerosis and confirmed the results in vivo using a vein graft mouse model.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Resident Stem/Progenitor Cells Are Present in the Adventitia of Vein Graft
As previously described by a substantial body of work, the early events after the establishment of a vein graft involve extensive cell loss. This is rapidly followed by an increase in inflammation and uncontrolled proliferation of the intima. 15 Consistently, we observed marked changes in cellular composition within the adventitia of vein grafts in a time-dependent manner ( Figure 1A-1F ). Indeed, we saw an expedition in the increment of cell numbers from 3 days after surgery onward ( Figure 1C-1F ) after an initial loss of cells (Figure1A and 1B) . Furthermore, various morphological changes were observed during the duration of vein grafting, including the formation of cell clusters surrounded by microvessels (Figure 1G and 1H; indicated by black arrows) and the presence of populations with large cellular nucleus (Figure 1D and 1E; indicated by white arrows). Importantly, the number of stem cell antigen (Sca)-1-positive cells were significantly increased during the development of vein graft arteriosclerosis ( Figure 1K ).
Previous work published by our group and others had identified a population of progenitor cells that reside within the adventitia under physiological conditions. 13 In light of the complexity and vast cellular compositions that were seen in our vein graft mouse model, which ultimately result in neointimal hyperplasia, we aimed to identify the presence of progenitor cells within the pathological vessel and investigated their persistence and contribution toward the process. Interestingly, we found that vein grafts at 4 weeks after implantation harbored a small but significant population of cells that express progenitor cell markers, such as Sca-1 ( Figure 1I and 1J), CD117, and CD34 ( Figure  IA , IB, and ID in the online-only Data Supplement); CD133 + cells were found to be <0.2%, and no obvious stage-specific embryonic antigen-1 + cells were identified ( Figure ID in the online-only Data Supplement). Approximately 12.6% of total cells within the adventitia were positive for macrophage marker, Mac-1 ( Figure IC and ID in the online-only Data Supplement).
It was intriguing to find that the Sca-1 + cells were localized in close proximity to CD31 + cells lining the vasa vasorum ( Figure 1I and 1J), thus postulating a putative role of vasa vasorum in sustaining the survival of Sca-1 + cells. Furthermore, we also detected the presence of smooth muscle cells (SMCs; α-smooth muscle actin-positive) that were found to envelope CD31 + cells that lined the vasa vasorum ( Figure IE in the online-only Data Supplement; indicated by white arrow). Taken together, it is plausible that the progenitor cells that we have identified to be localized within the adventitia of vein grafts may contribute to the pathology of atherosclerosis, potentially via their differentiation into SMCs. Figure III in the online-only Data Supplement indicate that adventitial stem cells are derived from the vessel wall, but not bone marrow cells. We next aimed to test their clonogenic capacity by conducting a limiting dilution assay. As a result, we found that ≈5% to 11% of cells developed a primary colony, and ≈30% of those colonies could be expanded further ( Figure 2A ). The morphology of cells appeared to be markedly variable among the different colonies, thus suggesting that several subpopulations of progenitors are present in the heterogeneous cultures ( Figure 2B ). Interestingly, although we found that the capacity of differentiation into the endothelial lineage was restricted to few clones ( Figure 2C ), we observed that all clones consistently showed the ability to differentiate into SMC ( Figure 2D and 2E). In addition to their clonogenicity, the adventitia-derived cells possessed multipotent differentiation capacities and were able to give rise to adipocytes, osteoblasts, and chondrocytes when cultured under specific differentiating conditions ( Figure IV in the online-only Data Supplement). Altogether, the results indicate that cells derived from the adventitia are both clonogenic and multipotent.
Clonogenicity and Differentiation of
Differentiation of Adventitial Sca-1 + Cells Into SMCs Is Dependent on Integrin/Collagen IV Interactions
In light of the data that we have obtained thus far, it is tempting to postulate that adventitial-derived progenitor cells (Sca-1 + ) can contribute to neointima formation after vein grafting, potentially via differentiation into SMCs. To confirm this, we isolated Sca-1 + cells from primary cultures using magnetic beads and subjected the cells to SMC differentiation in the presence of collagen IV. Using real-time polymerase chain reaction, we found that collagen IV significantly induced gene expression levels of a panel of SMC markers (SM22α, calponin, α-smooth muscle myosin heavy chain, and α-smooth muscle actin; Figure 3A ). We confirmed the induction of SMC differentiation at the protein level using immunofluorescence staining ( Figure 3B ) and Western blotting ( Figure 3C ). Concomitantly, the differentiation of progenitor cells caused a decrease in the expression levels of progenitor cell markers, such as Sca-1, CD34, and CD117 ( Figure 3D ). Taken together, the data showed that Sca-1 + progenitor cells derived from the adventitia can differentiate into mature SMC in vitro and, therefore, are likely to participate in the process of neointima formation after vein grafting. Cloning efficiency of adventitial cell populations. Cultured adventitial cells were cloned using a limiting dilution assay, and ≈6% of the cells were able to form clones and ≈20% of those were expanded (A). Phase contrast images show variable morphologies of the clones (B). The clones were differentiated either into smooth muscle cells (SMC) by culturing the cells in collagen IV-coated plates for 6 days or into endothelial cells in media containing 50 ng/mL vascular endothelial growth factor for ≥7 days. Cells were harvested for gene expression analysis of endothelial (C) or smooth muscle markers (D) using real-time reverse transcriptase-polymerase chain reaction. Data are means±SEM (n=3); *P<0.05. SMC markers smooth muscle actin (α-SMA), calponin, myosin heavy chain (SMMhC), and SM22α were strongly expressed by the majority of clones during differentiation at the protein level (E).
Next, we aimed to elucidate the mechanisms that are involved in SMC differentiation of the progenitor cells. Figure 4A showed that progenitor-SMC differentiation resulted in a marked increase in the expression of several integrins, namely α4, α5, and β1. Consistently, focal adhesion kinase was also found to be activated ( Figure 4B ), thereby supporting the involvement of integrins in the differentiation process. To confirm the direct role of integrins in inducing SMC differentiation, the progenitor cells were pretreated with an RGD (Arg-Gly-Asp) peptide G4391 for 30 minutes to antagonize integrin function before differentiation; RGD peptide S3771 and dimethyl sulfoxide were also used as controls. Data from Western blot showed a marked inhibition of calponin as a result of treatment of RGD peptide G4391, thus confirming the interaction of integrin/collagen IV in regulating progenitor cell differentiation into SMCs.
Adventitial Progenitor Cells Migrate Into Decellularized Vessel Wall in Response to SDF-1
Recently, we have established an ex vivo bioreactor model in which thoracic aorta from mice was decellularized by an overnight treatment with SDS before perfusion with a circulation of culture medium. As a result, translucent acellular vessel scaffolds were generated, whereby fluorescent staining of the vessels with 4',6-diamidino-2-phenylindole (blue) was undetectable, thus indicating the absence of any cell nuclei ( Figure 5A) .
In this study, we aimed to evaluate the migratory capacities of adventitial Sca-1 + progenitor cells into the acellular scaffold and their subsequent in situ differentiation into SMCs. In consideration that stromal cell-derived factor (SDF)-1 has been established for its role as a potent chemoattractant and is abundantly secreted by key cellular players (ie, macrophages) during atherosclerosis, we wondered whether the chemokine could induce the migration of progenitor cells into decellularized vessels. To address this question, Sca-1 + progenitor cells were applied to the external side of the vessel and allowed to migrate in response to exogenous SDF-1 that was added into the circulating medium. Normal culture medium in the absence of SDF-1 was used as a control. Although we found that a small number of progenitor cells could actively migrate into the scaffold wall in the absence of exogenous stimuli ( Figure 5B ), the addition of SDF-1 significantly enhanced the number of migrating cells in the decellularized vessels ( Figure 5C and 5D) . The chemotactic response toward SDF-1 (A and B) . Adventitial Sca-1 + cells were pretreated with RGD peptide G4391 (0.5 mmol/L) for 30 minutes at 37°C before SMC differentiation for 6 days. RGD peptide S3771 (0.5 mmol/L) or dimethyl sulfoxide (DMSO) was also used as control. Cells were harvested for protein expression analysis with Western blotting (C). GADPH was used as a loading control.
may not be surprising because the progenitor cells were found to express consistent, albeit low, levels of the SDF-1 receptor C-X-C chemokine receptor 4 ( Figure VA in the onlineonly Data Supplement). Interestingly, cells that migrated into decellularized vessel walls expressed marked levels of the SMC marker, SM22α ( Figure 5E ). In contrast, the expression levels of the endothelial cell marker, CD31, were not detectable ( Figure 5F ).
To verify the role of SDF-1/C-X-C chemokine receptor 4 axis in progenitor cell chemotaxis, we performed in vitro scratch assays as well as transwell experiments. As expected, the scratch assay indicated a dose-dependent upregulation of Sca-1 + progenitor cell chemotaxis in response to SDF-1 ( Figure  VB and VC in the online-only Data Supplement). Furthermore, a significant increase in the number of cells that have migrated to the underside of a 0.8-µm pore size Transwell in response to SDF-1 was demonstrated ( Figure VD and VE in the online-only Data Supplement), thus confirming the role of SDF-1/C-X-C chemokine receptor 4 axis in progenitor cell chemotaxis. Taken together, these results indicate the capacity of Sca-1 + adventitial cells to migrate through the vessel wall for subsequent differentiation into SMCs in situ. This phenomenon implicates their potential role in neointima formation in vivo.
Adventitial Sca-1 + Cells Enhance Atherosclerosis of Vein Grafts
Although hematoxylin and eosin-stained sections from freshly harvested vena cava of apolipoprotein E-deficient mice showed an integrated endothelium and 2 layers of cellular composition between the intima and media ( Figure 6A) , we observed the formation of neointimal lesions that were composed of >20 layers of cells in vena cava that was grafted into the carotid artery, most of which consisted of foam cells ( Figure 6B ; indicated by black arrows). To confirm the role of adventitial Sca-1 + progenitor cells on lesion formation in vivo, the cells were applied to the external side of vein grafts before isografting into apolipoprotein E-deficient mice. Vein grafts in the absence of Sca-1 + progenitor cell seeding were used as a control. To demonstrate the fundamental contribution of the vessel wall, vein graft segments were also irradiated before isografting to prevent cell proliferation. In the controls, atherosclerotic lesions were found to be markedly reduced, showing detachment of neointimal lesions from the rest of the vessels ( Figure 6C ). In contrast, the seeding of Sca-1 + progenitor cells significantly restored atherosclerotic lesion thickness, as shown in Figure 6D and 6E. These results highly suggest that adventitial stem/progenitor cells that enveloped the outer layer of the grafts could enhance atherosclerosis formation by direct migration from the adventitia into the intima.
To clarify the contribution of adventitial tissues and bone marrows to neointimal formation, adventitial tissue of normal vein from wild-type mouse was carefully removed and replaced by the adventitia derived from SM22-LacZ mouse, which was grafted into wild-type animals. In addition, adventitial tissue of vein from SM22-LacZ mouse was replaced by the adventitia derived from wild-type mouse, which was grafted into wild-type mice. Vein grafts were harvested 4 weeks postoperatively, sectioned, and stained with X-gal and nucleus. Data shown in Figure VI in the online-only Data Supplement indicate that adventitial stem cells could contribute to ≈30% of SMCs in neointimal lesions of the grafts. To explore the possible contribution of adventitial stem cells to other cell types within neointimal lesions, chimeric mouse models were established by bone marrow transfer as described previously. We observed that bone marrow-derived cells mostly contribute to + cells were seeded in the outer layer of a decellularized mouse thoracic aorta in a bioreactor system, either in the presence or absence of 100 ng/mL SDF-1 in the circulating medium. After 7 days, the vessels were harvested and stained either with 4',6-diamidino-2-phenylindole (DAPI) to detect cell nuclei (A-D) or with CD31-fluorescein isothiocyanate and SM22α-PE (E and F, respectively). Graph in D represents means±SEM from 3 independent experiments. Three vessels were used in each experiment; *P<0.05. 
Discussion
In this study, our vessel graft models of wild-type and apolipoprotein E-deficient mice revealed that the adventitia of pathological vein grafts harbors a significant population of progenitor/stem cells that display active involvement in the development of the disease. Furthermore, we provided new findings that demonstrate the existence of stem cell niche-like structure within the adventitia of vein grafts, some of which were located close to the vasa vasorum and other cell components. These stem/progenitor cells possessed clonogenicity and were able to differentiate into SMCs, endothelial cells, and other mesenchymal lineages. It was, however, noteworthy that most clones, if not all, had the capacity to differentiate into SMCs. Furthermore, the mechanism of SMC differentiation was found to be dependent on collagen/integrin interactions. Interestingly, adventitial stem/progenitor cells displayed chemotactic properties ex vivo, in which they actively migrated from the adventitial side into the vessel wall, thus enhancing vein graft atherosclerosis in apolipoprotein E-deficient mice. Therefore, these findings support the notion that during pathological conditions such as in vein grafting, the adventitia may harbor stem/progenitor cells that can actively participate in neointimal formation by direct differentiation into SMCs.
The identification of colocalized stem/progenitor cells with the vasa vasorum within the adventitia of vein graft emerged as one of the key findings in this study. Although the progenitor cells are likely to reside within these specialized niches for survival, potentially via the uptake of growth factors and nutrients that are provided by the vasa vasorum, the mechanisms of progenitor cell release and mobilization from their respective niches for deployment into specific sites within the vessel remain unclear. Furthermore, to date, there remains a lack of direct evidence that elucidates stem cell mobilization from the adventitia. More recently, accumulating data indicate the roles of proinflammatory cytokines and chemokines (ie, tumor necrosis factor-α, interleukin-1, transforming growth factor-β, interleukin-8, and SDF-1) in promoting the perpetuation of adventitial inflammation, 5, [16] [17] [18] [19] [20] some of which could potentially play a role in stem cell mobilization. The present study showed that inflammatory cells, such as macrophages, were mainly located in the adventitia of vein graft, thus postulating a potential role of cytokines and chemokines in direct or indirect mobilization of progenitor cells within the adventitia. Interestingly, several studies have shown that SDF-1 and granulocyte colony-stimulating factor can enhance the mobilization of progenitors in circulation. [21] [22] [23] [24] [25] Indeed, we subsequently demonstrated that the chemokine, SDF-1, was able to drive progenitor cell migration into decellularized vessels of ex vivo bioreactor systems. Although the advential progenitor cells responded chemotactically toward exogenous SDF-1, other molecules, such as fibroblast-specific protein 1 and monocyte chemoattractant protein-1, may also appear as promising candidates owing to the following evidence: (1) fibroblast-specific protein 1 secreted by bone marrow-derived inflammatory cells can chemoattract and induce SMC proliferation, 26 and (2) blocking of monocyte chemoattractant protein-1 in vein grafts resulted in a significant reduction in neointimal lesions as a result of inhibition of cell migration. 27 Besides serving as a reservoir of progenitor cells for mobilization in response to appropriate cues, it is noteworthy that vasa vasorum may also act as a means of transport for mobilized progenitor cells to migrate into the intima, where they subsequently proliferate or differentiate into SMCs in response to microenvironmental cues.
Previously, a study using a rat arterial injury model showed that exogenously modified and injected carotid adventitial fibroblasts, but not resident fibroblasts, can migrate from the adventitia toward the luminal side in response to SMC. 28, 29 Although elevated stretch stress as a result of vein grafting led to either apoptosis or necrosis of a majority of endothelial cells and SMCs within the vessel wall, 3 it was also shown that ≈60% of SMCs in atherosclerotic lesions of vein grafts were derived from the vessel wall. 30 In the present study, we found that as a result of irradiation, the cells in vein grafts appeared to have lost their ability to migrate and proliferate. Furthermore, the vein graft adventitia-derived Sca-1 + progenitor cells were able to migrate into the intima of vein grafts, thereby enhancing the development of lesions. These data might give an alternative explanation as to why the SMCs within neointimal lesions display a specific migratory and proliferative phenotype. 31 These may reflect different populations or stages of differentiation in the contribution of adventitial progenitor cells to neointimal formation. 31 Recently, the origins of SMCs found in neointimal lesions have attracted much interest. 32 Traditionally, it is believed that mature SMCs in the media can alternate from a contractile to a synthetic phenotype in response to vessel injury. 33 These SMCs can then migrate into the intima where they subsequently form lesions. 34 However, a recent report indicated that medialderived mature SMCs were neither capable of migrating nor proliferating, as indicated by in vitro aorta explant cultures and in vivo vessel injury models. 35 Instead, SMCs displaying a synthetic phenotype were mostly, if not all, derived from stem cells present in the vessel wall. 35 Although our study cannot exclude the migration of medial SMC into neointimal lesions, our data support the notion that adventitial stem/progenitor cells actively contribute to SMC accumulation within the neointima of vein grafts. These findings, together with reports from several other groups, 13 may significantly develop our understanding of the potential effects of resident stem cells on vascular pathophysiology, indicating a possible mechanism for stem cells in the remodeling of vein grafts. Together, these findings have some implications for clinical application in the future. For instance, a current strategy for treatment of restenosis is to inhibit SMC proliferation, but the outcome of the clinical end point for the patients was not satisfactory. With the knowledge of stem cell contribution to neointimal formation, a new strategy to direct stem cell differentiation could be considered, for example, enhancing stem cell differentiation toward endothelial lineage to repair the damaged vessels, which may lead to significant improvement for clinic therapy.
Although data that address the mechanisms of adventitia stem cell differentiation into SMCs remain scarce, recent evidence using different progenitor cells indicates the involvement of various signal transductions and signaling pathways in driving the differentiation process. 36, 37 The most established mechanism by which SMC differentiation is regulated is via the binding of transcription factors, serum response factor and myocardin, to the CArG element of promoter regions of SMC genes, thus leading to the initiation of gene transcription. 38, 39 Previous data from our laboratory demonstrated that several signal transducers, including Nrf3-Pla2g7/Nox4-induced H 2 O 2 , histone deacetylase 7, and heterogeneous nuclear ribonucleoproteins, serve either as enhancers or inhibitors of stem cell differentiation toward the SMC lineage. [40] [41] [42] [43] [44] In the present study, we confirmed that the interaction of integrins α4/α5 and β1 with matrix protein domains of collagen IV is crucial for adventitial stem cell differentiation as identified by blocking peptides for integrin receptors. As our ex vivo data on adventitial stem cell migration into decellularized vessel wall indicated an abundance of cells that expressed smooth muscle markers, it is plausible that the infiltrated progenitor cells were driven toward SMC differentiation as a result of direct contact with matrix proteins within the vessel wall. This finding implicates that the directionality and lineage fate of the adventitial progenitor cells could be determined by their active interaction with environmental matrix proteins.
In summary, the present study provided evidence that stem/ progenitor cells predominantly reside within close proximity to the vasa vasorum during pathological conditions of vein grafts. Furthermore, we demonstrated that adventitial progenitor cells can migrate across the vessel wall in response to SDF-1 for subsequent differentiation into SMCs, a process mediated by matrix protein/integrin interactions. Altogether, our findings postulate an active contribution of the progenitor/ stem cells in the pathogenesis of atherosclerosis in vein grafts, thereby providing more understanding and clarity of disease processes within the vessel wall.
